Skip to main content
. 2020 Nov 30;8(4):520. doi: 10.3390/healthcare8040520

Table 1.

Characteristics of women with fibromyalgia from the two groups at baseline.

Characteristics GLG (n = 26) a PG (n = 24) a p
Age (years) 56.19 (7.97) 53.74 (11.50) 0.382 *
Date when fibromyalgia symptoms started 1994 (11.86) 1992 (12.56) 0.601 *
Date of diagnosis 2006 (6.56) 2003 (7.02) 0.935 *
Height (cm) 157.08 (4.55) 156.29 (6.08) 0.541 *
Weight (kg) 64.26 (9.67) 61.30 (13.24) 0.411 *
Muscle mass (%) 61.97 (7.17) 64.82 (8.58) 0.245 *
Fat mass (%) 34.81 (7.51) 32.24 (7.75) 0.285 *
BMI (kg/m2) 26.05 (3.75) 25.06 (4.75) 0.522 *
Physical Activity (hours per week) 2.96 (1.88) 2.32 (1.43) 0.203 *
Income (euros). GLG: n = 23; PG: n = 19 1624 (895) 1573 (853) 0.849 *
Type of treatment n (%) b
Number of participants with nonpharmacological treatment 20 (76.9) 18 (75) 0.874 **
Number of participants without nonpharmacological treatment 6 (23.1) 6 (25)
Number of participants with pharmacological treatment 13 (50) 12 (50) 1.000 **
Number of participants without pharmacological treatment 13 (50) 12 (50)
Educational Qualifications (%) b
No education (able to read and write) 4 (15.4) 2 (8.3) 0.048 **
Elementary school 13 (50) 7 (29.2)
Secondary school 4 (15.4) 13 (54.2)
University diploma 3 (11.5) 1 (4.2)
University degree 2 (7.7) 0 (0)
PhD 0 (0) 1 (4.2)
Occupational status n (%) b
self-employed 2 (7.7) 0 (0) 0.167 **
paid employment 3 (11.5) 7 (29.2)
Civil servant 6 (23.1) 2 (8.3)
Unemployed 6 (23.1) 2 (8.3)
Retired 3 (11.5) 5 (20.8)
Housewife 6 (23.1) 7 (29.2)
Student 0 (0) 1 (4.2)

a Values expressed as means (SD). b Values expressed as n (%). GLG: Ganoderma lucidum group; PG: placebo group; BMI: body mass index; * p: value of the Student’s t-test. ** p: value of the chi-squared test.